These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9075138)

  • 21. Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane.
    Mortier S; Faict D; Schalkwijk CG; Lameire NH; De Vriese AS
    Kidney Int; 2004 Sep; 66(3):1257-65. PubMed ID: 15327425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of TNFalpha and interleukin-6 by peritoneal macrophages after overnight dwells with bicarbonate- or lactate-buffered dialysis fluid.
    Liberek T; Lichodziejewska-Niemierko M; Knopinska-Posluszny W; Schaub TP; Kirchgessner J; Passlick-Deetjen J; Rutkowski B
    Perit Dial Int; 2002; 22(6):663-9. PubMed ID: 12556067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized long-term evaluation of bicarbonate-buffered CAPD solution.
    Feriani M; Kirchgessner J; La Greca G; Passlick-Deetjen J
    Kidney Int; 1998 Nov; 54(5):1731-8. PubMed ID: 9844152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of bicarbonate/lactate peritoneal dialysis solutions on human mesothelial cell proliferation ex vivo.
    Bajo MA; del Peso G; Castro MA; Díaz C; Castro MJ; Gil F; Sánchez-Tomero JA; Selgas R
    Adv Perit Dial; 2001; 17():37-41. PubMed ID: 11510293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The application of animal models to study the biocompatibility of bicarbonate-buffered peritoneal dialysis solutions.
    ter Wee PM; Beelen RH; van den Born J
    Kidney Int Suppl; 2003 Dec; (88):S75-83. PubMed ID: 14870880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuous dialysis with bicarbonate/lactate-buffered peritoneal dialysis fluids results in a long-term improvement in ex vivo peritoneal macrophage function.
    Jones S; Holmes CJ; Mackenzie RK; Stead R; Coles GA; Williams JD; Faict D; Topley N
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S97-103. PubMed ID: 11792769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biocompatibility and tolerability of a purely bicarbonate-buffered peritoneal dialysis solution.
    Weiss L; Stegmayr B; Malmsten G; Tejde M; Hadimeri H; Siegert CE; Ahlmén J; Larsson R; Ingman B; Simonsen O; van Hamersvelt HW; Johansson AC; Hylander B; Mayr M; Nilsson PH; Andersson PO; De los Ríos T
    Perit Dial Int; 2009; 29(6):647-55. PubMed ID: 19910566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model.
    Mortier S; Faict D; Lameire NH; De Vriese AS
    Kidney Int; 2005 Apr; 67(4):1559-65. PubMed ID: 15780112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biocompatibility of new peritoneal dialysis solutions: clinical experience.
    Garcia-Lopez E; Lindholm B; Tranaeus A
    Perit Dial Int; 2000; 20 Suppl 5():S48-56. PubMed ID: 11229612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Automated peritoneal dialysis with 'on-line'-prepared bicarbonate-buffered dialysate: technique and first clinical experiences.
    Brunkhorst R; Fromm S; Wrenger E; Berke A; Petersen R; Riede G; Westphale J; Zamore E; Ledebo I
    Nephrol Dial Transplant; 1998 Dec; 13(12):3189-92. PubMed ID: 9870487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in peritoneal response after exposure to low-GDP bicarbonate/lactate-buffered dialysis solution compared to conventional dialysis solution in a uremic mouse model.
    Vila Cuenca M; Keuning ED; Talhout W; Paauw NJ; van Ittersum FJ; Ter Wee PM; Beelen RHJ; Vervloet MG; Ferrantelli E
    Int Urol Nephrol; 2018 Jun; 50(6):1151-1161. PubMed ID: 29728994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of pH-neutral, bicarbonate-buffered dialysis fluid on peritoneal transport kinetics in children.
    Schmitt CP; Haraldsson B; Doetschmann R; Zimmering M; Greiner C; Böswald M; Klaus G; Passlick-Deetjen J; Schaefer F
    Kidney Int; 2002 Apr; 61(4):1527-36. PubMed ID: 11918761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro biocompatibility performance of Physioneal.
    Hoff CM
    Kidney Int Suppl; 2003 Dec; (88):S57-74. PubMed ID: 14870879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of a new bicarbonate/lactate-buffered neutral peritoneal dialysis fluid for peritoneal failure in patients undergoing peritoneal dialysis.
    Hoshino T; Ishii H; Kitano T; Shindo M; Miyazawa H; Yamada H; Ito K; Ueda Y; Kaku Y; Hirai K; Mori H; Ookawara S; Tabei K; Morishita Y
    Discov Med; 2016 Feb; 21(114):81-8. PubMed ID: 27011043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of heat shock protein 72 in peritoneal leukocytes is induced by peritoneal dialysis.
    Marzec L; Liberek T; Chmielewski M; Bryl E; Witkowski JM; Liberek K; Zdrojewski Z; Rutkowski B
    Perit Dial Int; 2007; 27(3):288-95. PubMed ID: 17468477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Better preservation of peritoneal morphologic features and defense in rats after long-term exposure to a bicarbonate/lactate-buffered solution.
    Hekking LHP; Zareie M; Driesprong BAJ; Faict D; Welten AGA; de Greeuw I; Schadee-Eestermans IL; Havenith CEG; van den Born J; Ter Wee PM; Beelen RHJ
    J Am Soc Nephrol; 2001 Dec; 12(12):2775-2786. PubMed ID: 11729248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biocompatible peritoneal dialysis solutions: do they indeed affect the outcome?
    Grzegorzewska AE
    Pol Arch Med Wewn; 2009 Apr; 119(4):242-7. PubMed ID: 19413184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of glucose and pyruvate in acidic and non-acidic peritoneal dialysis fluids on leukocytes cell functions.
    Mahiout A; Matata BM; Brunkhorst R
    Kidney Int; 1997 Mar; 51(3):860-7. PubMed ID: 9067922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro effects of bicarbonate- versus lactate-buffered continuous ambulatory peritoneal dialysis fluids on peritoneal macrophage function.
    Fischer FP; Schenk U; Kiefer T; Hübel E; Thomas S; Yatzidis H; Mettang T; Kuhlmann U
    Am J Kidney Dis; 1995 Dec; 26(6):924-33. PubMed ID: 7503067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of pure bicarbonate-buffered peritoneal dialysis fluid reduces the incidence of CAPD peritonitis.
    Montenegro J; Saracho R; Gallardo I; Martínez I; Muñoz R; Quintanilla N
    Nephrol Dial Transplant; 2007 Jun; 22(6):1703-8. PubMed ID: 17405794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.